Kechuang Bio's brain-computer connection technology is leading in several aspects. First, it has a high recognition rate, secondly, it has a wide recognition range, and thirdly, it requires few electrode points.
Products like the one released by Neuralink, a company owned by Musk, require the implantation of more than 3,000 electrodes in the brain to detect the activity of neurons.
Kechuang Biotech does not need to implant electrodes, and only needs about a hundred electrodes. The recognition success rate is also far higher than that of its peers. The gap is between laboratory products and commercial products.
In the field of biomedicine, the gap between the level of Zheng Li and Blue Star is wider than the gap between Nobel Prize winners in biology and high school students.
The key to the brain-computer connection that Zheng Li took out was to solve the problem of too many neuron signals in the brain. How to filter out the unnecessary neuron signals through a filtering algorithm, leaving only the neural signals that I need to identify.
Ren Yong was not frustrated by Cheng Gang's rejection. The most important thing for him to come this time was to express his gratitude and express his hope to maintain a long-term cooperative relationship with Kechuang Biotech.
As for Hope Kechuang Biotech’s refusal to authorize Samsung and Apple, it’s best if it can be implemented, but it doesn’t matter if it’s not possible.
Because if he were a science and technology creature, he wouldn't do this.
He just regretted not investing in Kechuang Biotechnology’s Series A round.
Nowadays, the domestic venture capital circle is talking about Lei Jun’s 50 million yuan to get 10% of the shares of Kechuang Biotech as a legend. Everyone thinks that Lei Jun is very lucky, and he invested 5000 yuan in less than two years. Ten thousand times doubled.
The success of Kechuang Biotech has also made it easy for some biopharmaceutical companies with core technologies to obtain large investments in recent years. For example, CMB International invested in five biopharmaceutical companies after failing to participate in Kechuang Biotech’s second round of investment.
One of the biopharmaceutical companies claims to develop an industrial synthesis route for endorphins that is different from that of Kechuang Biotechnology.
Ren Yong: "I completely understand your company's decision. In the future, Huawei hopes to cooperate deeply with your company in the field of brain-computer connection. Brain-computer connection can not only be applied to individuals, but also to Industry 4.0."
After the mobile phone business has stagnated due to the blockade and even its market share has continued to decline, Huawei hopes that the smart industry will become its next profit growth point.
Cheng Gang nodded and said, "I will give feedback to Director Zheng."
Cheng Gang knew that he was not a direct descendant of Zheng Li, so he was very cautious in his position as the general manager of Kechuang Biotechnology and would report any important matters to Zheng Li.
Ren Yong continued: "When will Director Zheng return to Suzhou? Mr. Yu expressed his wish to have a face-to-face conversation with Director Zheng before I came."
Cheng Gang replied: "Director Zheng will not return to China in the near future. First, due to the impact of the epidemic, returning home will require at least a fourteen-day quarantine period. Director Zheng is a workaholic, and if he is quarantined in a hotel for fourteen days, he may go crazy. "
"In addition, the current brain-computer connection technology of Kechuang Biotech is only effective for people of yellow race, Chinese-speaking people."
"Director Zheng is currently conducting research and development on brain-computer connection in other mainstream languages."
A speculative article about the impact of language family on brain nerve signals was published in the latest issue of Nature.
Although Zheng Li's guess is not supported by sufficient experimental data, Zheng Li is now a top expert in the field of brain-computer connection, and his guess can be published.
In California, thousands of miles away from Suzhou, Neuralink has obtained Kechuang Biotech's test products through Apple.
After they reported the test data to Musk, Musk, known as Iron Man, became furious:
"You told me in 2018 that we would operate the iPhone through brain-computer connection. Three years later, our laboratory products are still imperfect."
Neuralink is a brain-computer connection company owned by Musk. Its leader stated in a speech at the California Academy of Sciences on July 17, 2019 that they plan to develop technology that allows people to directly control iPhones with their brains.
“The accurate recognition rate of our lab’s brain-computer connection products on mobile phones is less than 50%.”
"The innovative biotechnology from China has been launched, and what you see before your eyes is their brain-computer connection technology!"
"The Chinese can achieve 99% recognition accuracy using this technology, and they don't need to implant damn electrodes into the brain!"
"Your idea is to develop a damn CPU and connect it to the brain through thin wires thinner than a human hair."
"What's even more ridiculous is how these sensors will be installed on the surface of the brain's skull and then transmit information to the wearable computer 'Link' located behind the ear."
"Don't you feel ashamed when you see the technology of Kechuang Biotechnology?"
"The solution you proposed is so backward and ridiculous, and more importantly, the technology is so backward that you haven't even put it into practice yet!"
Neuralink plans to use this method, the brain can be connected to the iPhone through the APP.
"Chinese companies can just wear earphones and control iPhones through consciousness. What about us? We need to implant the damn sensors on the surface of the brain's skull."
"Don't you think this is very cyberpunk! It's cool! Those addicts who have taken dama will not hesitate to put a knife in their heads and implant our electrode sensors into it!"
Musk couldn't restrain his anger because he originally thought that his Neuralink was at the forefront of brain-computer connection.
It turned out that Neuralink, a Chinese company I had never heard of before, could not even see its taillights.
Hordak is the president of Neuralink, and he was sweating profusely after being trained by Musk.
Musk's external image is that of a passionate and approachable entrepreneur, but within the company he is an out-and-out "tyrant."
Hordak explained: "Sorry, Kechuang Biotechnology may have taken a completely different technical route from ours. I just need a little time to catch up with them."
Musk asked: "Why are we still doing experiments on damn monkeys when Kechuang Biotech's brain-computer connection has been successfully commercialized?"
"When can we start human trials?"
Neuralink’s previous brain-computer connection experiments have been conducted on monkeys.
Hodak: "Our human experiments have not yet been approved by the FDA, and it may still take time."
Musk said helplessly: "Why must our experiments be conducted in Amerikan? We can't set up a R&D center in the Lion City like Kechuang Biotech and conduct experiments in Southeast Asia where supervision is not so strict?"
Musk has already read the information of Kechuang Biotechnology. He believes that the important reason why the other company's progress is ahead of Neuralink is that they started human experiments very early.
Neuralink has never conducted human trials.
Hordak explained: "We are using invasive brain-computer connection, and supervision will be stricter on our approach. Kechuang Biotech's brain-computer connection is non-invasive."
